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Abstract
The cycle inhibiting factor (Cif) produced by enteropathogenic and enterohemorrhagic Escherichia coli was the first
cyclomodulin to be identified that is injected into host cells via the type III secretion machinery. Cif provokes cytopathic
effects characterized by G1 and G2 cell cycle arrests, accumulation of the cyclin-dependent kinase inhibitors (CKIs) p21
waf1/
cip1 and p27
kip1 and formation of actin stress fibres. The X-ray crystal structure of Cif revealed it to be a divergent member of
a superfamily of enzymes including cysteine proteases and acetyltransferases that share a conserved catalytic triad. Here we
report the discovery and characterization of four Cif homologs encoded by different pathogenic or symbiotic bacteria
isolated from vertebrates or invertebrates. Cif homologs from the enterobacteria Yersinia pseudotuberculosis, Photorhabdus
luminescens, Photorhabdus asymbiotica and the b-proteobacterium Burkholderia pseudomallei all induce cytopathic effects
identical to those observed with Cif from pathogenic E. coli. Although these Cif homologs are remarkably divergent in
primary sequence, the catalytic triad is strictly conserved and was shown to be crucial for cell cycle arrest, cytoskeleton
reorganization and CKIs accumulation. These results reveal that Cif proteins form a growing family of cyclomodulins in
bacteria that interact with very distinct hosts including insects, nematodes and humans.
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Introduction
Pathogenic bacteria have developed sophisticated arsenals of
virulence factors that hijack eukaryotic host functions to their own
benefit. One of the pathways targeted by several bacterial effectors
is the eukaryotic cell cycle. These toxins, termed cyclomodulins,
can promote cell proliferation or, conversely, inhibit cell growth
and modulate differentiation by blocking cell cycle progression
[1,2]. The Cycle Inhibiting Factor (Cif) is a cyclomodulin injected
into eukaryotic cells by the type III secretion system (T3SS) of
enteropathogenic and enterohemorrhagic Escherichia coli (EPEC
and EHEC). Cif from pathogenic E. coli triggers an irreversible
cytopathic effect characterized by cell cycle arrests at the G2/M
and G1/S phase transitions and, at least in HeLa cells,
reorganization of the actin network [3–6]. In contrast to other
cyclomodulins such as the cytolethal distending toxin [7] or
colibactin [8], Cif is not a genotoxin nor an activator of DNA-
damage checkpoint pathways that lead to phosphorylation of
cyclin-dependent kinase 1 and consequent G2-arrest [5]. Both G1
and G2 arrests induced by Cif are correlated with the
accumulation of the cyclin-dependent kinase inhibitors (CKIs)
p21
waf1/cip1 and p27
kip1 (hereafter referred as p21 and p27), which
actively participate in the control of cell cycle progression. These
accumulations result from inhibition of their proteasome-mediated
degradation [6].
Cif is composed of a C-terminal active domain (residues 21–
282) and an exchangeable N-terminal translocation signal encoded
by the first ,20 amino acids [9]. The crystal structure of a
truncated form of EPEC Cif (lacking the first 99 amino acids) was
recently determined. The presence of a conserved catalytic triad
comprising Cys109, His165 and Gln185, revealed that Cif is a
divergent member of a superfamily of enzymes that includes
cysteine proteases, acetyltranferases and transglutaminases [10].
The three amino acids that comprise the triad are essential for
Cif’s ability to induce cytopathic effects in eukaryotic cells as
mutation of these residues leads to loss of function [10].
In EPEC and EHEC, Cif is not encoded within the locus of
enterocyte effacement (LEE), which includes T3SS machinery
genes and other effectors, but by a temperate lambdoid phage
[11]. The cif gene has been widely disseminated by phage
conversion within the natural population of E. coli, but positively
selected within LEE-encoding strains [11]. Since Cif targets the
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4855cell cycle, a fundamental process conserved in all eukaryotic cells,
it is reasonable to speculate that Cif homologs contribute to the
pathogenicity of other bacterial species.
In the present study, four homologs of Cif have been identified
and characterized in pathogenic or symbiotic bacteria: Burkholderia
pseudomallei, Yersinia pseudotuberculosis, Photorhabdus luminescens and
Photorhabdus asymbiotica. The four Cif homologs are functional and
induce cell cycle arrest, p21 and p27 accumulation and actin
cytoskeleton rearrangement in HeLa cells in an identical manner
to EPEC Cif. The catalytic triad identified in the EPEC Cif crystal
structure is strictly conserved in the homologs (at the sequence
level) and is involved in their cytopathic activity since mutation of
the critical cysteine residue leads to loss of function. Therefore, Cif
proteins form a conserved family of cyclomodulins present in both
symbionts and pathogens of vertebrate and invertebrate hosts.
Results
Genes encoding Cif-like proteins are present in the
genomes of Yersinia, Burkholderia and Photorhabdus
species
The cyclomodulin Cif was initially identified and characterized
in pathogenic E. coli (CifEc) [3]. Sequence database searches using
BLAST [12] revealed that CifEc shares similarity with hypothetical
proteins encoded by the genome of four other bacterial species
(Table 1). CifEc exhibited a high degree of similarity with Ypk1971
(56% identity), a protein encoded by the human pathogen Yersinia
pseudotuberculosis strain YPIII [13]. Y. pseudotuberculosis infection in
humans causes gastroenteritis characterized by a self-limited
mesenteric lymphadenitis that mimics appendicitis. CifEc was also
similar to a protein encoded by the open reading frame bpss1385
from B. pseudomallei strain K96243 (26% identity). B. pseudomallei is
the causative agent of melioidosis, an important cause of sepsis in
east Asia and northern Australia [14]. Putative Cif homologs were
also detected in two Photorhabdus species: P. luminescens, a symbiotic
bacterium for the soil nematode Heterorhabditis and a pathogen for
a broad range of insects [15] and P. asymbiotica, an emerging
human pathogen [16]. The proteins encoded by plu2515 (P.
luminescens) and pha4011 (P. asymbiotica) share 23 and 26% of
identity with CifEc respectively. Interestingly, these four bacterial
species in which cifEc-like genes were found all possess at least one
T3SS. Proteins Ypk1971, Bpss1385, Plu2515 and Pha4011 are
hereafter referred to as CifYp, CifBp, CifPl and CifPa respectively.
Finally, it should also be noted that a truncated putative protein
(GOS5485515) obtained from the translation of a DNA fragment
isolated from surface water marine samples [17,18] also shows
sequence similarity to CifEc.
The degree of conservation and the phylogenetic relationship
between Cif homologs were analysed by constructing a multiple
sequence alignment and a phylogenetic tree using the Neighbour-
Joining method (Fig. 1). CifPl and CifPa clustered together and
were separated from a second group consisting of CifEc and CifYp.
CifBp was the most divergent protein, located to a branch between
the two groups. This phylogenetic tree matches the accepted
bacterial taxonomy since B. pseudomallei belongs to the b-
proteobacteria class whereas all others are enterobacteriacae
belonging to the c-proteobacteria class.
Genes encoding Cif-like proteins are found in highly
rearranged DNA regions
In E. coli,t h ecif gene is located on an inducible lambdoid
prophage spread widely amongst EPEC and EHEC strains (Fig. 2)
Table 1. Cif homologs characterization and sequence conservation with CifEc.
Proteins Bacterial origin To Cif from E. coli GC content (%) Accession number
Identity (%) Similarity (%) cif genes
whole
genome
CifEc Escherichia coli - - 41 50 AAQ07241
CifYp (Ypk1971) Yersinia pseudotuberculosis 56 72 43 47 ACA68260
CifBp (Bpss1385) Burkholderia pseudomallei 26 45 51 68 CAH38859
CifPl (Plu2515) Photorhabdus luminescens 23 42 33 43 CAE14889
CifPa (Pha4011) Photorhabdus asymbiotica 26 46 30 42 n/a
GOS5485515 n/a 51 66 n/a n/a ECE73989
(compared to the first 159 residues)
doi:10.1371/journal.pone.0004855.t001
Figure 1. Phylogenetic relationship between CifEc, CifYp, CifBp,
CifPl and CifPa. A multiple alignment of the protein sequences (see
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a region displaying a high degree of similarity to a prophage
described in Serratia entomophila (Fig. 2) [19]. This prophage is
integrated 5 to 6 times in the genome of both Photorhabdus species
[20] and encodes genes for several putative virulence factors,
notably a putative T3SS effector protein homologous to YopT from
Yersiniae. This phage has no homology with the lambdoid prophage
found in E. coli isolates but displays some similarity to bacteriocins
and R-type pyocins [21]. In B. pseudomallei strain K96243 (Fig. 2),
cifBp is located between two vestigial transposase genes on
chromosome II near the hrp cluster, which codes for one of the
three T3SS present in B.pseudomallei[22]. Comparison ofsequenced
genomes from different B. pseudomallei strains reveals that the
organization of this locus is highly variable. B. pseudomallei strains
S13 and 9 contain additional genes, encoding putative transposases,
which are inserted near cifBp (Fig. 2). In B. pseudomallei strain 1106a,
this region is deleted and cifBp is absent. These data suggest that
DNA transposition events could have lead to the heterogeneous
distribution of the cifEc-like gene in B. pseudomallei strains. Among the
sequenced strains of Y. pseudotuberculosis, only the strain YPIII
possesses a gene with similarity to cifEc. Comparison of the genetic
environment between YPIII and other Y. pseudotuberculosis strains
revealed that cifYp is positioned within a chromosomal locus
previously described as the insertion site of ypm, a gene coding for
a superantigenic toxin in strain AH [23]. Both ypm and cifYp are
located downstream of a 26-bp sequence called yrs which is
homologous to dif, a site-specific recombination target used by
filamentous bacteriophages for host chromosome integration.
Deletions in the yrs locus occur at a higher frequency compared
to others regions within the chromosome [23]. Genetic instability at
this locus could explain the heterogeneous distribution of both cifYp
and ypm genes in the Y. pseudotuberculosis population.
In conclusion, each cifEc-like gene is associated either with
mobile genetic elements, such as phages, or is located in region of
Figure 2. Genetic organization of the cif-like genes loci from E. coli strain B171, P. luminescens strain TT01, P. asymbiotica strain
ATCC43949, B. pseudomallei strains K96243, S13, 9 and 1106a and Y. pseudotuberculosis strains YPIII, AH and 9314/74. Open reading
frames (ORFs) are represented by horizontal arrows and designation of first and last ORF from each schematic are indicated. Vertical arrows indicate
position of the yrs sequence (Yersinia recombination site).
doi:10.1371/journal.pone.0004855.g002
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by horizontal gene transfer in all these bacterial species. This is in
agreement with the observation that each cifEc-like gene has a
different GC content compared to that of their cognate host
genome (Table 1).
Cif proteins share common conserved motifs, including a
catalytic triad
Database searches with the sequence of CifEc or the Cif
homologs (including the truncated protein from the marine
metagenome) reveals no significant matches to well-characterized
proteins or motifs. However, alignment of CifEc and the homolog
sequences reveals several well conserved positions or regions, most
of which are located to the C-terminal two thirds of the proteins
(Fig. 3A). The lack of sequence conservation at the far N-terminus
(top panel in Fig. 3A) is consistent with the putative function of
these regions as a translocation signal for the T3SS, which may
have different requirements in the different parent organisms. It is
now well established that regions responsible for secretion/
translocation and chaperone binding in T3SS effectors are located
to the N-terminus, but often share no sequence similarity, even for
effector proteins translocated by the same T3SS [24].
Sequence alignments of the Cif protein family identified a
conserved cysteine residue. Conservation of cysteine residues often
implies biological significance. The recent crystal structure of CifEc
revealed that C109 forms part of a catalytic triad. Further, the
other two residues that form this structural motif (H165 and Q185)
are also fully conserved in all Cif homologs (Fig 3A). In addition to
the catalytic triad, several other residues are also retained. The
position of these residues, when mapped onto the structure of CifEc
(possible for all but three of the conserved residues which are not
present in the construct crystallised) reveals they cluster in three
regions (Fig. 3B). The first of these clusters surrounds the active site
and these residues are likely essential for retaining the catalytic
triad in a suitable conformation to enable catalysis, or are directly
involved in substrate binding (residues with carbon atoms coloured
yellow in Fig. 3B). The second cluster (residues with carbon atoms
coloured green in Fig. 3B) is somewhat distant from the active site
and it seems likely that this region is important for maintaining
structural integrity, with a potentially important hydrogen bond
identified between the O
d1 atom of Asp170 (located at the end of
b-strand 2) and the OH atom of Tyr265 (located at the end of b-
strand 4). The importance of the third cluster (of three residues) is
less apparent (residues with carbon atoms coloured purple in
Fig. 3B). This region may be involved in binding substrate
molecules, or it may interact with the N-terminal region of CifEc
not present in the crystallised protein. In conclusion, in silico
analyses of Cif homologs are consistent with a conserved function
for these proteins, akin to CifEc.
CifBp is injected by the EPEC T3SS and induces cell cycle
arrest and stress fibre formation in HeLa cells
An EPEC strain deleted for its chromosomal cifEc gene (E22Dcif)
has previously been described [3]. To test whether the Cif-like
proteins are functional homologs of CifEc, the E22Dcif strain was
complemented with a plasmid encoding each of the cifEc-like
genes, and these bacteria were used to infect cultured HeLa cells.
Since the whole amino acid sequence of the putative protein
derived from the marine metagenome is not available, this
truncated protein was not included in these assays. Before
phenotypic characterization of cells infected with EPEC producing
the Cif homologs, the translocation efficiency of the proteins by
the EPEC T3SS was monitored using the TEM/CCF2 assay [9].
As expected, the CifEc-TEM fusion protein was properly
translocated, as demonstrated by detection of intracellular b-
lactamase activity (Fig. 4A). TEM activity was also detected in cells
infected with E22Dcif producing CifBp-TEM, but levels of b-
lactamase activity for CifPl-TEM, CifPa-TEM and CifYp-TEM
were similar to the basal level detected with the negative control
(TEM alone, Fig. 4A). Since TEM fusion proteins were produced
to similar levels in the bacteria (Fig. 4A), absence of intracellular
TEM activity likely results from inefficient recognition and/or
injection of CifPl-TEM, CifPa-TEM and CifYp-TEM by the T3SS
of EPEC. The lower translocation level of CifBp-TEM compared
to CifEc-TEM probably also reflects a poor recognition of the
secretion/translocation signal (STS) of CifBp by the T3SS from
EPEC. Indeed, when this fusion protein was expressed in an escN
mutant (T3SS ATPase defective mutant), b-lactamase activity was
no longer detected in infected cells, confirming that translocation
of CifBp-TEM by E22 strain is T3SS-dependent (data not shown).
Since CifBp can be injected by the T3SS of E22, the capacity of
the protein to induce cytopathic phenotypes on HeLa cells was
analysed using the infection model. In contrast to cells infected
with E22Dcif carrying an empty vector, cells infected with E22Dcif
producing CifBp developed cell distension and actin stress fibres
indistinguishable from those induced by a CifEc-expressing strain
(Fig. 4B). CifBp also blocked cell cycle progression, as demonstrat-
ed by the accumulation of G2 arrested cells containing 4N DNA
content (Fig. 4B). These phenotypes were not induced when CifBp
was expressed in an escN mutant (data not shown). These data
clearly demonstrate that CifBp is a functional homolog of CifEc.
CifPl, CifPa and CifYp are functional homologs of CifEc
As the EPEC T3SS was not able to translocate CifPl,C i f Pa and
CifYp into infected cells, the cytopathic activity of these CifEc-like
proteins was investigated using purified recombinant samples
combined with a lipid mediated delivery system (BioPORTER) as
previously described [5]. The effects of CifBp delivered with this
system were also investigated. CifBp, CifPl and CifPa were all readily
overexpressed and purified in a soluble form (see Materials and
Methods). However, despite many efforts, it was not possible to
obtain a purified soluble form of CifYp at levels necessary for activity
assays using the BioPORTER delivery system. As previously
reported [5], treatment of HeLa cells with BioPORTER mixed
with purified CifEc leads to cell enlargement and formation of actin
stress fibres (Fig. 5), identical to the phenotype observed with the
infection model. However, as protein delivery with BioPORTER is
not as efficient as bacterial infection [5], only ,50% of the treated
cells exhibit morphological alterations (not shown). Studies of cell
cycle patterns were therefore realized using G1/S synchronized cells
to improve visualization of G2 arrest. In contrast to cells incubated
with the lipid delivery agent mixed with PBS alone, cells treated
with BioPORTER+CifEc accumulated in G2 phase (38% of CifEc-
treated cells contained 4N DNA-content against 10% for PBS-
treated cells). Lipofection of purified CifBp into HeLa cells led to
actin stress fibres and cell accumulation in G2 phase (27%) (Fig. 5),
confirming the functionality of CifBp observed with the infection
assays. Introduction of purified CifPl or CifPa into HeLa cells with
BioPORTER also led to cell enlargement, cytoskeleton alteration
and accumulation of cells with 4N DNA content (40 and 25% for
CifPl and CifPa respectively versus 10% for PBS treated cells, see
Fig. 5). Therefore, CifPl and CifPa are also functional homologs of
CifEc. As these phenotypes are observed with purified proteins, the
results demonstrate that the proteins alone are sufficient to induce
the Cif-associated cytopathic effects.
As it was not possible to introduce CifYp into cells using either
the infection or BioPORTER treatments, the function of this
Cif Functional Homologs
PLoS ONE | www.plosone.org 4 March 2009 | Volume 4 | Issue 3 | e4855Figure 3. The three residues of the CifEc catalytic triad are conserved among members of the Cif protein family. (A) ClustalW
alignment between CifEc, CifYp, CifBp, CifPl, CifPa and GOS_5485515. Fully conserved residues are indicated by a red background and amino acids
conserved more than 60 or 80% are indicated by a yellow or an orange background respectively. The cysteine, histidine and glutamine residues that
form the catalytic triad of CifEc are indicated with blue stars. (B) Position of the fully conserved residues in the three dimensional structure of CifEc.
Side chain carbon atoms of residues comprising the catalytic triad are coloured cyan. The remaining fully conserved residues cluster in three regions,
as described in the text. Residues coloured yellow, including glycine positions indicated by spheres, are P107, G110, A113, N159, L163-G164, S186-
G189, G191, D200-W201; in green are D170, D172, E264-D266; in purple are K118-L119 and N273.
doi:10.1371/journal.pone.0004855.g003
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PLoS ONE | www.plosone.org 5 March 2009 | Volume 4 | Issue 3 | e4855Figure 4. CifBp is injected by the EPEC T3SS and induces cell cycle arrest and stress fibre formation in HeLa cells. (A) Translocation of
CifEc-TEM, CifBp-TEM, CifPl-TEM, CifPa-TEM and CifYp-TEM fusions by the T3SS of EPEC strain E22. Hela cells were loaded with CCF2/AM substrate and
were infected for 2 and a half h with E22Dcif hosting plasmids expressing TEM alone or the different Cif-TEM fusions. Upper panel: intracellular b-
lactamase activity detected by measuring cleavage of the CCF2/AM, as described in Material and Methods. This ratio represents the relative
translocation efficiency [9]. Experiments were performed in triplicate and error bars represent standard errors of the mean. Lower panel: synthesiso f
TEM fusions proteins were quantified in bacteria just before the translocation assays by western blot with anti-TEM antibodies. (B) G1/S synchronized
HeLa cells were exposed for 90 min to E22Dcif hosting either empty vector or the plasmids expressing CifEc or CifBp, washed and incubated with
antibiotic for 20 or 72 h. Upper panels: F-actin was labelled with phalloidin-rhodamine (red) and DNA with DAPI (blue) 72 h post-infection. Bars
represent 20 mm. Lower panels: cell cycle distribution was analysed by flow cytometry 20 h post-infection. 2N and 4N populations are indicated.
doi:10.1371/journal.pone.0004855.g004
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CifYp and CifEc, used as a positive control, were expressed as a
translational fusion with the fluorescent reporter protein GFP,
allowing quantification of GFP-Cif expression in transfected cells.
GFP alone was also transfected as a negative control. Among the
GFP positive population, 96% of cells expressing GFP-CifEc had a
2N DNA content whereas the 2N population of cells expressing
GFP alone was only 82% (Fig. 6). Consistent with previous studies
demonstrating that Cif could also induce G1/S arrest [6], this
result demonstrates that the cell cycle of transfected cells
expressing GFP-CifEc was blocked in G1 (2N DNA content). As
expected, the cell cycle arrest was not observed when the critical
cysteine residue from the catalytic triad of CifEc was substituted
(Fig. 6). Expression of GFP-CifYp in HeLa cells also led to
accumulation of GFP-positive cells with 2N DNA content (96%
against 82% for cells expressing GFP alone), demonstrating that
CifYp induced a cell cycle arrest in G1 phase similarly to CifEc
(Fig. 6). This result indicates that Cif from Y. pseudotuberculosis is a
functional homolog of CifEc.
The conserved catalytic triad is critical for the activity of
Cif homologs
Most of the conserved residues in Cif proteins are clustered in
discrete regions (Fig. 3). The cysteine, histidine and glutamine
residues forming the catalytic triad in CifEc were shown to be
critical for activity [10]. To determine whether an equivalent
functional catalytic site exists in the Cif homologs, the conserved
cysteines in CifBp, CifPl and CifPa (C90, C128 and C123
respectively) were substituted with a serine residue, and the
corresponding proteins were purified prior to delivery into HeLa
cells using the BioPORTER system. In contrast to the wild-type
proteins, the cysteine variants did not induce cell enlargement and
stress fibre formation (Fig. 7A). Further, analysis of DNA content
revealed that accumulation of G2-arrested cells did not occur
when cells were treated with the cysteine variants (Fig. 7B).
Expression of the cysteine variant from CifYp by transfection in
HeLa cells also revealed that the cell cycle was not arrested in
contrast to cells producing the wild-type protein (Fig. 6). These
results demonstrate that the conserved cysteine residue is critical
for Cif activity. Also, as the histidine and glutamine residues that
complete the triad are also conserved in the sequences of the Cif
homologs, this suggests that catalytic triads also exist in CifBp,
CifPl, CifPa and CifYp.
Cif homologs induce p21 and p27 accumulation in cells
It has recently been shown that the cytopathic activity of CifEc is
correlated to the accumulation of CKIs p21 and p27, two
important regulators of cell cycle progression [6]. Since all Cif
homologs appear to share the same catalytic triad and induce
identical cytopathic phenotypes in HeLa cells, we wonder if they
could hijack the same signaling pathways, despite the fact that two
of these proteins are produced by bacteria colonizing insects and
nematodes. Western-blot analysis of HeLa cells treated with
purified Cif homologs indicated that levels of p21 and p27 increase
in the presence of wild-type CifBp, CifPl and CifPa (Fig. 8). An
intact catalytic triad is integral to this accumulation as CKIs levels
were not affected when cells were treated with the cysteine variants
(Fig. 8). This accumulation of p21 and p27 suggests that the
molecular mechanisms involved in Cif cytotoxicity on HeLa cells
are identical for CifEc and the Cif homologs.
Discussion
CifEc proteins belong to a family of cyclomodulins that inhibit
host cell proliferation by inducing G1/S and G2/M phase
transition blocks [3,6]. In this study, functional homologs of Cif
Figure 5. Lipofection of purified CifBp, CifPl and CifPa proteins into HeLa cells induce cell cycle arrest and stress fibres formation
akin to CifEc. G1/S synchronized HeLa cells were treated with purified proteins or PBS in combination with a lipidic delivery agent (BioPORTER).
Upper panels: F-actin was stained with phalloidin-rhodamine (red) and DNA with DAPI (blue) 72 h post-treatment. Bars represent 20 mm. Lower
panels: cell cycle distribution was analysed by flow cytometry 20 h post-treatment. Percentages of cells with 4N DNA content are indicated.
doi:10.1371/journal.pone.0004855.g005
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B. pseudomallei, P. luminescens and P. asymbiotica. These homologs
possess the same capacity as CifEc to induce cell cycle arrest, actin
stress fibre formation and p21 and p27 CKIs accumulation when
introduced into HeLa cells, suggesting they target the same
substrates. Each of the Cif homologs possesses a predicted catalytic
triad as identified in the crystal structure of CifEc. This triad is
involved in the cytotoxic activity of each Cif homolog as
substitution of the conserved cysteine residue in any of the
proteins leads to inactivation.
In pathogenic E. coli, cif is located on an inducible lambdoı ¨d
prophage that has spread widely within the natural population of
E. coli [11]. Analysis of the genetic locus containing cif in other
bacteria reveals that cif genes from Photorhabdus species are also
located downstream of a prophage, while cif from B. pseudomallei
and Y. pseudotuberculosis are inserted in highly rearranged DNA
regions leading to heterogeneous distribution within bacterial
populations. In addition, GC content of cif genes shows substantial
deviation from the general pattern within their respective genome.
In light of these data, cif genes are proposed to have been acquired
by horizontal gene transfer and could be defined as xenologs
according to the nomenclature proposed by Koonin et al. [25].
The phylogenetic relationship between the different xenologs is in
agreement with the bacterial taxonomy since Cif from B.
pseudomallei, the only b-proteobacteria, is the most divergent
protein. This indicates that protein sequence variation is, to some
extent, a consequence of speciation events and suggests that cif
genes were probably acquired early during bacterial evolution. All
Cif-producing bacteria encode at least one T3SS that could inject
the effector into host cells during infection. It is interesting to
speculate that tight association between horizontally acquired
effectors and the T3SS machinery in bacteria is a consequence of
selective pressure since advantages conferred by effector acquisi-
tion will occur only if the recipient organism produces the
secretion/translocation machinery. Such an association has
already been described in E. coli and Salmonella enterica serovar
Typhimurium where phage-encoded T3SS effectors were associ-
ated with T3SS producing isolates [11,26].
Bacteria habouring the cif gene spend part of their life cycle in
association with eukaryotic organisms. While E. coli, B. pseudomallei,
Y. pseudotuberculosis and P. asymbiotica are mammalians pathogens
[13,14,16,27], both Photorhabdus species are pathogenic for insects
and symbiotic to nematodes [15,28,29]. Like the Cif proteins,
other families of T3SS effectors are produced by bacterial
pathogens that target distinct hosts. For example, a number of
proteins belonging to the YopT cysteine protease family have been
described in mammalian, insect and plant pathogens [30].
Although the overall sequence identity at the amino acid level is
not extensive, every member of the YopT family shows several
invariant residues including a cysteine, a histidine and an aspartate
that form a putative catalytic triad. Representatives from the
YopT-like family interfere with diverse host immune responses
and display protease activity dependent on an intact catalytic triad.
YopT, the archetypal member of this family, is the most potent
inhibitor of phagocytosis produced by Yersinia [31] and cleaves
prenylated GTPases of the Rho family in host cells [32]. Similar to
YopT, LopT from P. luminescens is able to release RhoA from
human and insect cell membranes [33]. AvrPphB is an avirulence
protein of the YopT-like family from the plant pathogen
Pseudomonas syringae that triggers a disease-resistance response in a
number of host plants, including Arabidopsis [30]. Searches of the
Protein Data Bank with the structure of CifEc reveal close
Figure 6. Transfection of CifYp induces cell cycle arrest in HeLa cells. HeLa cells were transfected with plasmid expressing GFP, GFP-CifEc or
GFP-CifYp (wild-type (WT) or Cys variants (C/A)) fusion proteins. GFP expression and DNA content were analysed by flow cytometry 48 h post-
transfection. Data are represented on two dimensional contour plot graphics with DNA content on the X-axis and GFP signal on the Y-axis. Gates
corresponding to the GFP negative and GFP positive populations are indicated. Among the GFP positive populations, percentages of cells with 2N or
4N DNA content are indicated within the corresponding quadrants.
doi:10.1371/journal.pone.0004855.g006
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the catalytic triad in each protein are different (C/H/D for
AvrPphB and C/H/Q for Cif), the overall folds and residues
comprising the catalytic triads superimpose well [10].
YopJ-like proteins form a second family of T3SS effectors
produced by different animal and plant pathogens that also possess
conserved residues forming a predicted catalytic triad, which is
required for protease activity [34]. YopJ, the archetypal member
of this family, is an essential virulence factor produced by Yersinia
which blocks MAPK and NFkB pathways resulting in inhibition of
host immune responses [35,36]. In contrast to members of the Cif
protein family, that induce similar phenotypes in HeLa cells,
proteins belonging to the YopT or the YopJ family appear to
generate different responses in eukaryotic cells. For example,
AvrA, a Salmonella YopJ-like T3SS effector (56% identity with
YopJ), does not induce the same host responses observed for YopJ
[37]. Further studies are required to determine whether the
conserved cytopathic effects induced by Cif proteins in HeLa cells,
notably cell cycle arrest, also occur in their respective host cells (gut
enterocytes for intestinal pathogens, insect cells for Photorhabdus
species, etc).
Interestingly, the plant symbiont Rhizobium sp. strain NGR234
produces NopJ, a YopJ-like protein and NopT, a T3SS effector
belonging to YopT-like family [38–40]. Both cysteine proteases
were shown to be involved in the host-specific nodulation response
of legumes [38,40]. Symbiotic bacteria deploy somewhat similar
Figure 7. Cysteine residues from predicted catalytic triads are essential for Cif homologs activity. (A) HeLa cells were treated with
purified Cif homologs proteins (wild-type (WT) or cysteine variants (C/S)) in combination with a lipidic delivery agent (BioPORTER). F-actin was stained
with phalloidin-rhodamine (red) and DNA with DAPI (blue) 72 h post-treatment. Bars represent 20 mm. (B) G1/S synchronized HeLa cells were treated
with PBS or purified Cif proteins (as indicated), in combination with BioPORTER. The percentages of the populations containing 4N DNA content were
determined by flow cytometry 20 h post-treatment.
doi:10.1371/journal.pone.0004855.g007
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pathogens. The T3SS is, for example, required for host cell invasion
by a variety of symbiotic bacteria [41–43]. As the Cif-producing
Photorhabdus species are not only insect pathogens but also nematode
symbionts, it is tempting to speculate that Cif may also contribute to
the symbiotic process. Further, CdtB, the active monomer of the
cyclomodulin CDT, is expressed in Hamiltonella defensa, a symbiont
of pea aphids [44]. It maybe that symbionts use cyclomodulins like
CDT and Cif to modulate, rather than globally deregulate, host
signalingpathways resultingininitiationofsymbiosis. Future studies
will rely on further molecular (in vitro) analysis and in vivo models to
achieve a full understanding of the roles of Cif in microbial
pathogenesis, commensalism and symbiosis.
Materials and Methods
Cell line, bacterial strains and plasmids
HeLa cells (ATCC CCL-2) were cultured in Dulbecco’s modified
Eagle medium (DMEM; Invitrogen) supplemented with 10% foetal
calf serum (FCS; Eurobio) and 80 mgm l
21 gentamicin at 37uCi na
5% CO2atmosphere. For synchronization in G1/Sphase,HeLacells
were treated with 2 mM thymidine (Sigma) for 18 h, washed 3 times
with Hank’s balanced salt solution (HBSS; Invitrogen), incubated in
normal medium for 9 h and treated again with 2 mM thymidine for
16 h. Bacterial strains and plasmids used in this study are listed in
Table 2. Bacteria were cultured in Luria-Bertani (LB) broth or in
interaction medium (DMEM with 25 mM Hepes and 5% FCS).
Antibiotics were used at the following final concentrations:
chloramphenicol 20 mgm l
21 and kanamycin 25 mgm l
21.
Construction of plasmids expressing Cif and Cif-TEM
proteins
To construct plasmids suitable for expressing Cif homologs from
B. pseudomallei, Y. pseudotuberculosis, P. luminescens and P. asymbiotica in
EPEC, cifBp, cifYp, cifPl and cifPa genes were amplified from
respective genomic DNA with primers adding a XbaI restriction
site at the start codon and a BamHI (or XhoI for cifBp) restriction site
after the stop codon. PCR products were digested and ligated into
the corresponding sites of the pBRSK vector [45]. The resulting
plasmids pEL1, pEL2, pEL4 and pEL5 contain, respectively, cifBp,
cifPl, cifPa and cifYp genes under the control of a Plac promoter.
To create the pKTEM vector necessary to construct TEM
fusions, the multiple cloning site and blaM gene (encoding the b-
lactamase TEM-1) were amplified by PCR from pCX340 ([9])
with primers containing XhoI and XbaI restriction sites. The PCR
fragment was digested and cloned into the corresponding sites of
pBBR1MCS-2 ([46]). Plasmids encoding translational fusion
between the different Cif proteins and the b-lactamase TEM-1
were obtained by cloning cif genes into the pKTEM vector.
Briefly, cifBp, cifPl, cifEc, cifPa and cifYp genes were amplified from
pEL1, pEL2, pEL3, pEL4 and pEL5 respectively using primers
with NdeI-EcoRI restriction sites (or XhoI-HindIII for pEL4),
digested and cloned into the corresponding sites of pKTEM.
The resulting plasmids pGJ719, pGJ720, pGJ626, pGJ721 and
pGJ803 encode CifBp-TEM, CifPl-TEM, CifEc-TEM, CifPa-TEM
and CifYp-TEM fusion proteins respectively. All the constructs
were verified by DNA sequencing (Cogenics, France).
Purification of CifBp, CifPl, CifPa and CifEc proteins
For production of recombinant protein, the genes encoding
cifBp, cifPl, cifPa and cifYp were cloned into the pET28a vector
(Novagen). The resulting constructs encoded proteins with an N-
terminal 6xHis tag. Plasmids were named pMB1, pCC1, pCC3
and pGJ803 respectively. The plasmid for expression of 6xHis-
CifEc has been described elsewhere [5]. Mutations of the
conserved cysteine residues were obtained by inverse PCR using
pET28 based constructs as a template and oligonucleotides
containing specific base changes. All the constructs were verified
by DNA sequencing (Cogenics, France). After transformation into
the E. coli BL21-CodonPlusH (DE3)-RIPL strain (Stratagene),
bacteria were grown in LB to an OD600 nm of ,0.6 then induced
with 0.5 mM IPTG for 3 h at 37uC. Purification of native proteins
was achieved by Ni-NTA chromatography as recommended by
the manufacturer (Qiagen) and, if necessary, gel filtration. Samples
were then dialysed against PBS, aliquoted and stored at 280uC.
Construction of plasmids expressing GFP-Cif fusion
proteins and transfection assays
Plasmids encoding translational fusions between the fluorescent
reporter protein GFP and CifEc or CifYp were obtained by cloning
cif genes (encoding the wild-type or the cysteine variant forms) into
the pTagGFP-C vector (Evrogen). The resulting plasmids were
verified by DNA sequencing (Cogenics, France). Transfections were
performed in 6-well plates with FuGENE (Roche) according to the
manufacturer’s instructions. Two days after transfection, HeLa cells
were exposed to trypsin, washed with ice-cold PBS, fixed for 3 h at
4uC in PBS with 1% formaldehyde, permeabilized overnight at 4uC
in PBS ethanol 70% and stained with propidium iodide for 30 min
at 37uC. Cells were analysed using a FACScalibur flow cytometer
(BectonDickinson)anddatafromatleast20 000cellswereanalysed
using FloJo software v8.5 (Tree Star).
Infection, translocation and BioPORTER assays
For infection experiments, bacterial strains were cultured
overnight in LB broth then diluted 1:100 in interaction medium
for 3 h at 37uC in a 5% CO2 atmosphere. HeLa cells were washed
with HBSS and infected for the indicated time in interaction
medium with a multiplicity of infection (MOI) of 100 bacteria per
cell (except as otherwise noted). After the infection, cells were
washed with HBSS then cultivated for the indicated times in
DMEM medium supplemented with 10% FCS and 200 mgm l
21
gentamicin.
Translocation levels of Cif-TEM fusion proteins were determined
using CCF2/AM (Invitrogen) as a substrate for intracellular TEM
enzyme as described previously [9]. Briefly, HeLa cells seeded in
black96-well plates were loaded for 1 h at 37uC with 1.7 mMC CF 2 /
AM diluted in DMEM with 2 mM probenecid and then infected for
Figure 8. Cif homologs induce p21 and p27 accumulation in
cells. HeLa cells were treated with PBS or purified Cif proteins (wild-
type (WT) or cysteine variants (C/S) as indicated), in combination with
BioPORTER. Cell extracts were probed with anti-p21, anti-p27 and anti-
actin antibodies 24 h post-treatment.
doi:10.1371/journal.pone.0004855.g008
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Fluorescence was quantified in a microplate reader (TECAN Infinite
M200) with excitation set at 410 nm (9 nm bandwidth) and emission
at 450 nm for blue fluorescence and 520 nm for green fluorescence
(20 nm bandwidth). Translocation was expressed as the emission
ratio at 450/520 nm. To determine the expression level of TEM
fusion proteins in bacteria, bacterial cultures with identical OD600 nm
were pelleted, resuspended in SDS-PAGE sample buffer, boiled for
5 min and subjected to western blot analysis with anti-TEM-1
antibodies (QED Biosciences).
For BioPORTER assays, 80 ml of purified proteins
(250 mgm l
21) (or PBS as a negative control) were added to one
BioPORTER tube (Genlantis) and resuspended in 420 or 920 ml
of DMEM. The samples were added to the cells grown in BD
Falcon culture slides or in 6-well plates and incubated for 4 h.
BioPORTER mixes were replaced by fresh complete medium and
the cells were incubated for 16–72 h.
Actin stress fibre and cell cycle analyses
For cell morphology and actin cytoskeleton visualization, cells
were fixed for 15 min in PBS supplemented with 4% formalde-
hyde, permeabilized with 0.1% Triton X-100 and stained with
rhodamine-phalloidin (Molecular Probes) and DAPI (Sigma).
Images were acquired with a DMRB fluorescence microscope
equipped with a DFC300FX digital camera (Leica). Cell cycle
distribution analyses were performed as previously described [47].
Briefly, cells were grown on 6-well plates, synchronized in G1/S
phase and infected or treated with BioPORTER. The cells were
exposed to trypsin, washed, fixed with ethanol, stained with
propidium iodide and analyzed by flow cytometry. Percentages of
G2 populations were calculated using the Dean-Jett-Fox model
from the FlowJo software (Tree Star).
Western Blot analyses
For Western blot analyses, 6610
5 cells were lysed in 80 mlo f
SDS-PAGE sample buffer, sonicated for 2 s to shear DNA and
then boiled for 5 min. Protein samples were resolved on 4–12%
NuPage gradient gels (Invitrogen) and blotted on PVDF
membranes. Membranes were blocked in TBST (10 mM Tris
pH 7.8, 150 mM NaCl, 0.1% Tween20) 5% non-fat dry milk,
then probed with primary antibody (0.5 mgm l
21) in TBST 5%
non-fat dry milk. Primary antibodies were: anti-actin (ICN), anti-
Table 2. E. coli strains and plasmids used in this study.
Strains and plasmids Genotype or description Reference
strains




pBRSK Cloning vector derived from pBR328 [45]
pEL1 pBRSK expressing CifBp This study
pEL2 pBRSK expressing CifPl This study
pEL3 pBRSK expressing CifEc [5]
pEL4 pBRSK expressing CifPa This study
pEL5 pBRSK expressing CifYp This study
pBBR1MCS-2 Low-copy cloning vector [46]
pKTEM TEM-1 fusion cloning vector derived from pBBR1MCS-2 This study
pGJ626 pKTEM expressing CifEc-TEM fusion This study
pGJ719 pKTEM expressing CifBp-TEM fusion protein This study
pGJ720 pKTEM expressing CifPl-TEM fusion protein This study
pGJ721 pKTEM expressing CifPa-TEM fusion protein This study
pGJ803 pKTEM expressing CifYp-TEM fusion protein This study
pET28a Protein expression vector Novagen
pMB1 pET28a expressing 6xHis-CifBp fusion protein This study
pMB2 pET28a expressing 6xHis-CifBp C90S fusion protein This study
pCC1 pET28a expressing 6xHis-CifPl fusion protein This study
pCC2 pET28a expressing 6xHis-CifPl C128S fusion protein This study
pCC3 pET28a expressing 6xHis-CifPa fusion protein This study
pCC4 pET28a expressing 6xHis-CifPa C123S fusion protein This study
pTagGFP-C Cloning vector for GFP translational fusion expression Evrogen
pRN1 pTagGFP-C expressing GFP-CifEc WT This study
pRN2 pTagGFP-C expressing GFP-CifEc C109A This study
pGJ808 pTagGFP-C expressing GFP-CifYp WT This study
pGJ809 pTagGFP-C expressing GFP-CifYp C117A This study
doi:10.1371/journal.pone.0004855.t002
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were visualized with horseradish peroxidase-conjugated secondary
antibody. Acquisitions were performed with a Molecular Imager
ChemiDoc XRS system (Bio-Rad). Protein levels were quantified
with Quantity One Software (Bio-Rad) and normalized with actin
level.
Bioinformatic analyses
The search for proteins sharing similarity with CifEc was
performed using BLAST on the NCBI server and MaGe system
on the Genoscope server for private access to the genome of P.
asymbiotica (Sanger Institute). Genetic organization of the cif-like
genes loci were determined using Artemis software from the
Sanger Institute and MaGe system. Multiple alignments of Cif
sequences were generated with ClustalW and edited using
GeneDoc software. Based on this alignment, the unrooted
phylogentic tree was obtained using Phylip’s Draw software.
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